[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PickingMyOwn Avatar @PickingMyOwn Panther

Panther posts on X about $abvx, $nktr, $capr, $pali the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% stocks XXXX%

Social topic influence $abvx #25, $nktr #4, $capr #3, $pali 18.75%, lack of 6.25%, $mreo 6.25%, dont get 6.25%, $2s 6.25%, i am 6.25%, $8m XXXX%

Top accounts mentioned or mentioned by @amaymd @wallstsai @houndcl @biobucks33 @tallnfat @andreagtc @mroliverbarnes @cpoption @rxgongivit2ya @charle77238 @bronxb_13 @thebiotechbear @bioluck80 @walterscottfund

Top assets mentioned AbbVie Inc (ABBV)

Top Social Posts

Top posts by engagements in the last XX hours

"@A_May_MD Im simply not long enough $ABVX lets see whats left. I can spare a kidney and my dog is cute. Not sure what hes worth on the open market. Not selling my wife or kid But Id be willing to farm them out for housework and car washing"
X Link 2025-12-06T01:19Z XXX followers, 1760 engagements

"@rxgongivit2ya Emil believes the lack of density intensifies fracture rates in common movements. Well see. The ph2b results make that case but in small sample size. $MREO"
X Link 2025-12-11T15:19Z XXX followers, XXX engagements

"$ABVX raised at $XX after data. You could have bought. $NKTR raised after data at $XX you could have bought. $CAPR raised after data at $XX. Just saying"
X Link 2025-12-12T14:47Z XXX followers, 3404 engagements

"I really dont get how $PALI isnt above $X. So I just keep nibbling"
X Link 2025-11-18T14:26Z XXX followers, XXX engagements

"$PALI should be $4+ with a legitimate possibility of a BO above $X. There are so many eyes (including mine) on $ABVX but this story is going to hit IMO. Adams breakdown is as always spectacular. Im simply astonished we can still add in the $2s"
X Link 2025-11-18T20:27Z XXX followers, 13.4K engagements

"$PALI is one of my favorites behind $ABVX and $NKTR and I believe it radically resets very soon if not acquired. The cap on PALI is teeny tiny. Yes its very early but IMO BP will take it. Sector is too hot to not for what amounts to a rounding error"
X Link 2025-11-26T12:42Z XXX followers, 3445 engagements

"@A_May_MD @houndcl @BioBucks33 $ABVX"
X Link 2025-12-03T23:34Z XXX followers, XXX engagements

"@A_May_MD @houndcl @BioBucks33 Thought about it overnight. $ABBV going after Obefazimod in such a helpless manner tells me they realize the asset is close to going into capable hands from a marketing and distribution standpoint. Otherwise silence is more prudent. $ABVX"
X Link 2025-12-04T14:22Z XXX followers, XXX engagements

"$CAPR joins the high probability buyout candidates $NKTR and $ABVX IMO. $XX to $70"
X Link 2025-12-08T16:12Z XXX followers, 5124 engagements

"@WallStSai $ABVX hottest commodity in biotech. Bidding war likely to end well above $200"
X Link 2025-12-09T15:10Z XXX followers, XXX engagements

"@tallnfat @charle77238 $ABVX I dont think so but you should sell and come back in 6mo. In a competitive buying environment bidders cant wait. Thats a guarantee loss of acquiring. Obefazimod is the absolute best acquisition target in bio right now. Nobodys waiting. But again you do you"
X Link 2025-12-12T13:11Z XXX followers, XXX engagements

"A little more on $CAPR FDA Approval mid XX launch of Deramiocel in XX. By 2031 projected annual revenue $1.1B with a guess profit margin of XX% on 52M shares = $XXXXX EPS with a 12X multiple = $XXX PPS. Just saying. It derisked and going to be SOC"
X Link 2025-12-12T15:19Z XXX followers, XXX engagements